CGEM Stock Analysis: Buy, Sell, or Hold?
CGEM - Cullinan Therapeutics, Inc. Common Stock
$17.76
0.46 (2.66%)
▲
5d:
+30.49%
30d:
+27.04%
90d:
+38.32%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When CGEM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: CGEM is 11.3% above its trading range ($15.96). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: CGEM is 11.3% above its trading range ($15.96). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: CGEM is currently trading at $17.76, which is considered extended relative to its 30-day fair value range of $13.35 to $15.96.
Technical Outlook: Technically, CGEM is in a uptrend. The price is approaching resistance at $17.40. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CGEM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $31.55 (+82.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CGEM is in a uptrend. The price is approaching resistance at $17.40. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CGEM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $31.55 (+82.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.35 -
$15.96
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BEARISH: Price significantly overextended (+11.3% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 82.3% below Wall St target ($31.55)
Trading Range Analysis
30-Day Trading Range
$13.35 -
$15.96
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$11.68
Resistance Level
$17.40
Current Trend
Uptrend
Technical data as of
Jun 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.84
Wall Street Target
$31.55
(+82.3%)
Share & Embed Analysis
Last updated: June 23, 2026 12:27 PM ET
Data refreshes hourly during market hours. Next update: 1:27 PM
Data refreshes hourly during market hours. Next update: 1:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGEM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Jennifer Michaelson
SELL
8000 shares
2026-03-05
Jennifer Michaelson
SELL
1780 shares
2026-02-25
Jacquelyn L Sumer
SELL
3601 shares
2026-02-24
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 56 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 56 HOLD |
